Erica Gibson
Family Medicine · Kansas City, MONPI 1932101631
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,255 and has fallen 98.6% since, to $17 in 2025.
Across 121 payments — averaging $13.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$176
- Pfizer$167
- GSK$164
- AstraZeneca$152
- Merck$132
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$125
- plus $680 from 11 others
What the payments were for
- Food & beverage$1,595100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $176 |
| Pfizer | 21 | $167 |
| GSK | 17 | $164 |
| AstraZeneca | 6 | $152 |
| Merck | 14 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $125 |
| Viiv Healthcare Company | 1 | $107 |
| Amgen | 7 | $100 |
| AbbVie | 5 | $92 |
| Astellas Pharma US Inc | 5 | $83 |
| Johnson & Johnson | 4 | $82 |
| Novo Nordisk | 6 | $81 |
| Boehringer Ingelheim | 3 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Abbott | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
How this compares
$1,595 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $1,914 |
| Rosuvastatin Calcium | 30 | $575 |
| Levothyroxine Sodium | 31 | $542 |
| Atorvastatin Calcium | 25 | $507 |
| Ezetimibe | 21 | $468 |
| Gabapentin | 31 | $458 |
| Losartan Potassium | 39 | $398 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $311 |
| Pantoprazole Sodium | 20 | $257 |
| Metoprolol Succinate | 15 | $212 |
| Lisinopril | 24 | $204 |
| Alendronate Sodium | 11 | $199 |
| Omeprazole | 14 | $164 |
| Zolpidem Tartrate ErZolpidem Tartrate | 14 | $155 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $152 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.